Panagora Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Panagora Asset Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-62,939	Closed	-$1.08M	–	2686
2017 Q1	$1.08M	Buy	62,939 +21,675	+53%	+$304K	﹤0.01%	1113
2016 Q4	$499K	Sell	41,264 -1,741	-4%	-$22.5K	﹤0.01%	1446
2016 Q3	$681K	Buy	43,005 +41,559	+2,874%	+$626K	﹤0.01%	1336
2016 Q2	$19K	Hold	1,446	–	–	﹤0.01%	2171
2016 Q1	$27K	Hold	1,446	–	–	﹤0.01%	2104
2015 Q4	$33K	Buy	1,446 +1,015	+235%	+$20.1K	﹤0.01%	2077
2015 Q3	$10K	Hold	431	–	–	﹤0.01%	2222
2015 Q2	$12K	Sell	431 -2,633	-86%	-$69K	﹤0.01%	2352
2015 Q1	$79K	Buy	+3,064	New	+$70.1K	﹤0.01%	1989

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Panagora Asset Management's XENT Position: Q2 2017 in Review

Panagora Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2017, closing a stake of 62,939 shares — an estimated $1.08M sold.

Panagora Asset Management first reported a position in XENT in Q1 2015 and held it in 9 quarters. The position peaked at $1.08M in Q1 2017. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2017.

Panagora Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2017 after selling out during the quarter.
Panagora Asset Management sold 62,939 Intersect ENT, Inc shares in Q2 2017, an estimated $1.08M.
Panagora Asset Management first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 9 quarters.
Panagora Asset Management's Intersect ENT, Inc position peaked at $1.08M in Q1 2017.
128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2017.

Based on Panagora Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.